Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The purpose of this exploratory subanalysis was to compare the effects of two depression quality improvement approaches on clinical outcomes and service utilization for individuals with comorbid depression/anxiety. This study used data from Community Partners in Care (CPIC), a cluster-randomized comparative effectiveness trial ( = 1,018; depression = 360; comorbid depression/anxiety = 658). Each intervention arm received the same quality improvement materials, plus either technical support (Resources for Services, RS) or support for collaborative implementation planning (Community Engagement and Planning, CEP). For the comorbid depression/anxiety subgroup, the collaborative planning arm was superior at improving mental health-related quality of life and mental wellness, as well as decreasing behavioral hospitalizations and homelessness risk at 6 months. The effects were not significant at 12 months. A collaborative planning process versus technical support for depression quality improvement can have short-term effects on mental wellness and social determinants of health among those with comorbid depression/anxiety.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422773 | PMC |
| http://dx.doi.org/10.1177/0193945918800333 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Associations Between Inflammatory and Catecholamine Markers and Clinical Outcomes in People with Post-Acute SARS-CoV-2 Infection.
Int J Gen Med
September 2025
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Purpose: The diagnosis of post-acute SARS-CoV-2 infection (PASC) is broad, referring to new or persistent health problems >four weeks after being infected with SARSCoV-2. The aim of this study was to determine whether cytokines, chemokines or catecholamine levels could specify the clinical condition.
Patients And Methods: Seventy-nine participants participated in person to study PASC.
Objective: To investigate the current status of comorbid anxiety and depression in adolescents with chronic kidney disease and to analyze their associated factors.
Methods: 105 adolescents with chronic kidney disease, hospitalized in the First Affiliated Hospital of Henan University of Traditional Chinese Medicine from May 2022 to May 2023, were selected through convenience sampling. A general information questionnaire, anxiety self-assessment scale, and depression self-assessment scale were used.
Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence.
Front Pharmacol
August 2025
Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Introduction: Depression and anxiety are prevalent comorbidities in individuals with chronic diseases, significantly impairing their quality of life and complicating disease management. Curcumin, derived from turmeric (Curcuma longa), has garnered attention for its potential therapeutic benefits in alleviating symptoms of depression and anxiety. However, its specific effects on depressive or anxiety symptoms associated with chronic diseases (DACD) remain unclear.
View Article and Find Full Text PDFChronic Pain and Late-Life Depression are Positively Associated in Chinese Centenarians and Oldest-Old Adults.
Depress Anxiety
September 2025
Department of Anesthesiology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan, China.
Aging is an inevitable process. Chronic pain and late-life depression frequently coexist in older adults. This study was aimed to explore the association between chronic pain and late-life depression in Chinese centenarians and oldest-old adults.
View Article and Find Full Text PDFScoping Review of Operative Management of Thoracic Malignancies in Patients With Psychiatric Comorbidities.
J Surg Res
September 2025
Department of Surgery, Keck School of Medicine of USC, Los Angeles, California. Electronic address:
Introduction: Psychiatric comorbidities are increasingly recognized in patients with thoracic malignancies. We undertook this scoping review to characterize the management of thoracic malignancies in patients with psychiatric illness and uncover any disparities in operative treatment or perioperative outcomes.
Methods: We conducted a scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.